14.3 Opioid Agonists and Antagonists

Opioid Agonists and Antagonists

Opioids are powerful analgesics that work by binding to specific receptors in the nervous system. They fall into two main categories: agonists, which activate opioid receptors to produce pain relief, and antagonists, which block those receptors to reverse or prevent opioid effects. Understanding both categories is essential for safe pain management and for responding to opioid emergencies.

Nurses are central to opioid safety. Proper assessment, careful dose titration, and thorough patient education help maximize pain relief while minimizing the real risks of respiratory depression, dependence, and overdose.

Opioid Agonists vs. Antagonists

Opioid agonists bind to and activate opioid receptors (mu, kappa, and delta), mimicking the body's own pain-relieving chemicals (endorphins, enkephalins, dynorphins). This activation produces analgesia along with other systemic effects. Commonly used agonists include morphine, oxycodone, fentanyl, hydromorphone, and codeine.

Opioid antagonists bind to the same receptors but do not activate them. By occupying the receptor, they block agonists from having an effect and can reverse opioid actions already underway.

• Naloxone (Narcan) is the go-to drug for reversing acute opioid overdose. It works within minutes (especially IV or intranasal) but has a short duration, so patients may need repeat doses or continued monitoring.
• Naltrexone is a longer-acting antagonist used in outpatient settings to help prevent relapse in opioid use disorder.

Mechanisms and Indications

Opioids bind to receptors in both the central and peripheral nervous systems. When mu receptors in particular are activated, pain signal transmission is inhibited and the brain's perception of pain is reduced. But opioid receptors aren't limited to pain pathways, which is why these drugs affect multiple body systems.

Common indications:

• Moderate to severe acute pain (post-operative, trauma)
• Chronic pain (cancer-related, palliative care)
• Cough suppression (codeine, hydrocodone)
• Diarrhea (loperamide, diphenoxylate act on gut opioid receptors with minimal CNS effects)

Major side effects to know:

• Respiratory depression is the most dangerous side effect and the primary cause of opioid-related death
• Constipation is the most common side effect and does not develop tolerance, meaning it persists with continued use
• Sedation and drowsiness
• Nausea and vomiting
• Pruritus (itching)
• Urinary retention
• Tolerance and physical dependence with prolonged use

Nursing Considerations for Opioids

Assessment

• Evaluate pain intensity, character, and location using an appropriate pain scale (numeric, FACES, or behavioral for nonverbal patients)
• Obtain baseline vital signs, paying close attention to respiratory rate and sedation level before administering
• Screen for contraindications and risk factors: respiratory disorders (COPD, sleep apnea), renal or hepatic impairment, history of substance use disorder, concurrent CNS depressant use

Administration

1. Follow the "5 rights" of medication administration: right patient, drug, dose, route, and time.
2. Start with the lowest effective dose and titrate based on the patient's pain response and side effects.
3. When switching between opioids or routes, use equianalgesic dosing charts to calculate equivalent doses. For example, 10 mg of IV morphine is roughly equivalent to 30 mg of oral morphine.
4. Never crush, chew, or split extended-release formulations. Doing so can release the full dose at once, risking fatal overdose.

Monitoring

• Reassess pain and sedation at regular intervals after administration (typically 15–30 min for IV, 1 hour for oral)
• Hold the dose and notify the provider if respiratory rate falls below 12 breaths/min or if the patient is difficult to arouse
• Have naloxone readily available, especially for opioid-naïve patients or those on high doses
• Monitor bowel function from the start. Prophylactic stool softeners or stimulant laxatives should be initiated with scheduled opioid therapy since constipation is expected and persistent.

Safety Measures

• Secure and properly store opioid medications to prevent diversion or misuse
• Dispose of unused or expired opioids according to institutional policy and DEA regulations
• Document opioid waste with a witness per facility protocol

Patient Education for Opioid Safety

Proper Use

• Take opioids exactly as prescribed. Do not adjust the dose or frequency without contacting the prescriber.
• Never crush, chew, or break extended-release or long-acting formulations.
• If a dose is missed, do not double up.

Side Effect Management

• Constipation: Start a stool softener (docusate) or stimulant laxative (senna) as recommended. Increase fluid and fiber intake.
• Nausea: An antiemetic may be prescribed for the first few days. Nausea often improves as the body adjusts.
• Report severe or persistent side effects (difficulty breathing, excessive drowsiness, severe itching) to the healthcare provider immediately.

Drug Interactions and Warnings

• Avoid alcohol and other CNS depressants (benzodiazepines, sedatives, muscle relaxants) unless specifically approved by the prescriber. Combining these with opioids dramatically increases the risk of respiratory depression.
• Inform all healthcare providers about current opioid use, including dentists and urgent care staff.

Overdose Awareness

Patients and caregivers should know the signs of opioid overdose:

• Pinpoint pupils
• Slow, shallow, or absent breathing
• Unresponsiveness or inability to be woken
• Bluish discoloration of lips or fingertips

If naloxone (Narcan) is available, educate the patient and family on how to administer it. Emphasize that naloxone wears off faster than most opioids, so calling 911 is still necessary even if the person initially responds.

Safe Storage and Disposal

• Store opioids in a locked location, out of reach of children and anyone without a prescription.
• Dispose of unused opioids through a drug take-back program or by following FDA guidelines (some can be flushed; others should be mixed with coffee grounds or kitty litter and placed in household trash).
• Never share opioids with anyone else, even if they have similar pain.

Opioid Use Disorder and Treatment

Opioid use disorder (OUD) is a chronic condition defined by problematic patterns of opioid use that cause significant impairment or distress. It involves changes in the brain's reward and stress circuits, which is why willpower alone is rarely sufficient for recovery.

The term opiate refers specifically to substances naturally derived from the opium poppy (morphine, codeine), while opioid is the broader term that includes synthetic and semi-synthetic drugs (fentanyl, oxycodone) as well as natural opiates. Both act on the same endogenous opioid system.

Medication-Assisted Treatment (MAT)

• Methadone: A long-acting full mu-receptor agonist. It reduces cravings and prevents withdrawal symptoms without producing the euphoric "high" at stable therapeutic doses. Dispensed through federally regulated opioid treatment programs (not standard pharmacies).
• Buprenorphine (Subutex) / Buprenorphine-naloxone (Suboxone): A partial mu-receptor agonist. Its ceiling effect means that beyond a certain dose, respiratory depression and euphoria plateau, making it safer than full agonists. Can be prescribed in office-based settings by qualified providers.
• Naltrexone (Vivitrol): A long-acting antagonist available as a monthly injection. It blocks opioid effects entirely, so the patient must be fully detoxed before starting it to avoid precipitating withdrawal.